InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Blakeman Shaun M., Chief Financial Officer. Officer active across 2 companies, notably Cantel Medical CORP. Cumulatively, 7 disclosures have been logged. History available since 13 May 2021. The latest transaction was filed on 17 March 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
25,000 shares0Common StockSEC:0001213900-23-021840:0
200,294 shares0Common StockSEC:0001213900-22-056946:0
25,000 shares0Common StockSEC:0001062993-22-006763:0
13,953 shares@ US$80.5948.9% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075843:0
13,953 shares@ US$80.5948.9% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075843
301 shares@ US$83.401.1% of flowCommon StockSEC:0000019446-21-000019
301 shares@ US$83.401.1% of flowCommon StockSEC:0000019446-21-000019:0
7 of 7 declarations
About Blakeman Shaun M.
Shaun M. Blakeman is the Chief Financial Officer at CANTEL MEDICAL CORP and SomaLogic, Inc. He is responsible for the financial management of these companies, overseeing financial operations and contributing to overall strategy. His expertise in finance is essential for ensuring the financial health and growth of the organizations.
